Riskpilot← Back to searchSign inGet full accessHELSEBOD AS
ASActiveOrg 916624425Cecilie Og Finn Kuhnle Paradisveien 91, Leilighet 29, 4012 StavangerActivities of trust, estate and agency accounts · NACE 6432Est. 20160 employees
Revenue 2025
NOK 0
EBITDA margin
—
+13% vs 2024
Equity ratio
68.9%
Financial strength
Net profit 2025
NOK 620K
+116% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -22K | +13% |
| Net profit | NOK 620K | +116% |
| Total assets | NOK 4,5M | +18% |
| Equity | NOK 3,1M | +18% |
| Employees | 0 | — |
Legal name
HELSEBOD AS
Org number
916624425
Legal form
Aksjeselskap
NACE code
6432 · Activities of trust, estate and agency accounts
Founded
26. januar 2016
Share capital
NOK 800 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Daglig leder alene. Styrets leder alene.
Company purpose
Investeringsvirksomhet herunder kjøp og salg av verdipapirer, kjøp og salg av fast eiendom samt andre aktiviteter i tilknytning til dette.
Address
Cecilie Og Finn Kuhnle Paradisveien 91, Leilighet 29, 4012 Stavanger
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −15 | −18 | −8 | −25 | −22 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −15 | −18 | −8 | −25 | −22 |
| Net financials | 609 | 11 | 319 | 313 | 642 |
| Profit before tax | 594 | −7 | 312 | 287 | 620 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 594 | −7 | 312 | 287 | 620 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 034 | 3 059 | 3 409 | 3 772 | 4 460 |
| Equity | 2 007 | 2 000 | 2 312 | 2 599 | 3 075 |
| Long-term debt | 1 027 | 1 059 | 1 097 | 1 173 | 1 241 |
| Short-term debt | 0 | 0 | 0 | 0 | 144 |
| Total debt | 1 027 | 1 059 | 1 097 | 1 173 | 1 385 |
EBITDA margin
-2200600.0%
This company
15.8%
Market median
-13927948% vs market
20212025
Equity ratio
68.9%
This company
38.2%
Market median
+80% vs market
20212025
Return on equity
20.2%
This company
18.4%
Market median
+10% vs market
20212025
Net profit margin
61963700.0%
This company
8.1%
Market median
+764983851% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.45×
This company
0.62×
Market median
+27% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EK Deputy Member | Deputy Member | 2016 |
NK Chief Executive Officer | Chief Executive Officer | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2016 | |
| Chairman | 2016 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HELSEBOD AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Elisabeth Kahrs Kuhnle | Deputy Member | 0 companies |
| Nicolay Kahrs Kuhnle | Chief Executive Officer | 0 companies |
| Finn Rieber Kuhnle | Board of Directors | 0 companies |
| Cecilie Heiberg Kuhnle | Chairman | 0 companies |